Apoptosis in systemic lupus erythematosus

Current Opinion in Rheumatology

Volumn 15, Issue 5, 2003, Pages 557-562

  White, Sarah ^a   Rosen, Antony ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Systemic lupus erythematosus; Tolerance

Indexed keywords

APOPTOSIS; B LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LYMPHOMA;

APOPTOSIS; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0042329608     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200309000-00006     Document Type: Review

References (49)

1. Radic MZ, Weigert M: Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol 1994, 12:487-520.
2. Diamond B, Katz JB, Paul E, et al: The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol 1992, 10:731-757.
3. Casciola-Rosen LA, Anhalt G, Rosen A: Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994, 179:1317-1330.
4. Miranda-Carus ME, Askanase AD, Clancy RM, et al.: Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol 2000, 165:5345-5351.
5. Price BE, Rauch J, Shia MA, et al.: Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta(2)-glycoprotein I-dependent manner. J Immunol 1996, 157:2201-2208.
6. Casciola-Rosen L, Rosen A, Petri M, et al.: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA 1996, 93:1624-1629.
7. McArthur C, Wang Y, Veno P, et al.: Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha. Arch Oral Biol 2002, 47:443-448.
8. Li H, Jiang YF, Cao H, et al.: Regulation of anti-phosphatidylserine antibodies. Immunity 2003, 18:185-192. This is the first demonstration of in vivo regulation of anti-PS B cells in the bone marrow.
9. Chen C, Nagy Z, Radic MZ, et al.: The site and stage of anti-DNA B-cell deletion. Nature 1995, 373:252-255.
10. Erikson J, Radic MZ, Camper SA, et al.: Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 1991, 349:331-334.
11. Retter MW, Nemazee D: Receptor editing occurs frequently during normal B cell development. J Exp Med 1998, 188:1231-1238.
12. Cocca BA, Seal SN, D'Agnillo P, et al.: Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A 2001, 98:13826-13831.
13. Tran HB, Macardle PJ, Hiscock J, et al.: Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum 2002, 46:1572-1579.
14. Clancy RM, Askanase AD, Kapur RP, et al.: Transdifferentiation of cardiac fibroblasts, a fetal factor in anti-SSA/Ro-SSB/La antibody-mediated congenital heart block. J Immunol 2002, 169:2156-2163.
15. Steinman RM, Nussenzweig MC: Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci U S A 2002, 99:351-358.
16. Savill J, Dransfield I, Gregory C, et al.: A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002, 2:965-975.
17. Pugh CW, Macpherson GG, Steer HW: Characterization of non-lymphoid cells derived from rat peripheral lymph. J Exp Med 1983, 157:1758-1779.
18. Huang FP, Platt N, Wykes M, et al.: A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000, 191:435-444.
19. Steinman RM, Turley S, Mellman I, et al.: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
20. Belz GT, Behrens GM, Smith CM, et al.: The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 2002, 196:1099-1104.
21. Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001, 19:47-64.
22. Hugues S, Mougneau E, Ferlin W, et al.: Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells. Immunity 2002, 16:169-181.
23. Liu K, Iyoda T, Saternus M, et al.: Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 2002, 196:1091-1097. This is an elegant study that reveals that endogenous apoptotic cell antigens actively tolerize antigen-specific T cells in vivo during normal homeostasis.
24. Chernysheva AD, Kirou KA, Crow MK: T cell proliferation induced by autologous non-T cells is a response to apoptotic cells processed by dendritic cells. J Immunol 2002, 169:1241-1250. This article is a further demonstration that both apoptotic cells, and their uptake by dendritic cells are important for T-cell proliferation in autologous mixed lymphocyte reaction (AMLR).
25. Kashipaz MRA, Huggins ML, Powell RJ, et al.: Human autologous mixed lymphocyte reaction as an in vitro model for autoreactivity to apoptotic antigens. Immunology 2002, 107:358-365. This study reveals that T-cell proliferation in the AMLR is dependent on apoptosis of the non-T-cell stimulator cells and suggests that AMLR may provide an in vitro model for the study of mechanisms in SLE.
26. Casciola-Rosen L, Andrade F, Ulanet D, et al.: Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med 1999, 190:815-826.
27. Casciola-Rosen LA, Anhalt GJ, Rosen A: DNA-dependent protein-kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med 1995, 182:1625-1634.
28. Utz PJ, Hottelet M, Schur PH, et al.: Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997, 185:843-854.
29. Doyle HA, Mamula MJ: Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001, 22:443-449.
30. Blanco P, Palucka AK, Gill M, et al.: Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543.
31. Bennett L, Palucka AK, Arce E, et al.: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003, 197:711-723. Microarray data demonstrate that expression of interferon-inducible genes correlates with disease activity in pediatric SLE patients.
32. Santiago-Raber ML, Baccala R, Haraldsson KM, et al.: Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 2003, 197:777-788. This report emphasizes a role for type I interferons in mouse models of SLE.
33. Leadbetter EA, Rifkin IR, Hohlbaum AM, et al.: Chromatin-IgG complexes activate B cells by dual engagement of IgM and toll-like receptors. Nature 2002, 416:603-607.
34. Morgan BP, Walport MJ: Complement deficiency and disease. Immunol Today 1991, 12:301-306.
35. Botto M, Dell'Agnola C, Bygrave AE, et al.: Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998, 19:56-59.
36. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blobs of apoptotic human keratinocytes-complement deficiency and systemic lupus erythematosus revisited. J Immunol 1997, 158:4525-4528.
37. Taylor PR, Carugati A, Fadok VA, et al.: A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000, 192:359-366.
38. Nauta AJ, Trouw LA, Daha MR, et al.: Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002, 32:1726-1736.
39. Baumgarth N, Chen J, Herzenberg LA: B-1 and B-2 cell-derived IgM antibodies are non redundant components of the humoral immune response to influenza virus infection. FASEB J 2000, 14:271-280.
40. Ehrenstein MR, Cook HT, Neuberger MS: Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 2000, 191:1253-1257.
41. Kim SJ, Gershov D, Ma XJ, et al.: I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 2002, 196:655-665. This report details the mechanism of IgM binding to the surface of apoptotic cells and subsequent complement deposition, suggesting a pathway to lupuslike pathology in the IgM-null mouse.
42. Atsumi G, Tajima M, Hadano A, et al.: Fas-induced arachidonic acid release is mediated by Ca2+-independent phospholipase A(2) but not cytosolic phospholipase A(2) which undergoes proteolytic inactivation. J Biol Chem 1998, 273:13870-13877.
43. Verbovetski I, Bychkov H, Trahtemberg U, et al.: Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 2002, 196:1553-1561.
44. Voll RE, Herrmann M, Roth EA, et al.: Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
45. Ronchetti A, Rovere P, Iezzi G, et al.: Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokines. J Immunol 1999, 163:130-136.
46. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002, 109:41-50.
47. Cohen PL, Caricchio R, Abraham V, et al.: Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002, 196:135-140.
48. Scott RS, McMahon EJ, Pop SM, et al.: Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 2001, 411:207-211.
49. Li RH, Chen J, Hammonds G, et al.: Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci 1996, 16:2012-2019.